z-logo
open-access-imgOpen Access
Caspase-3 is Dually Regulated by Apoptogenic Factors Mitochondrial Release and by SAPK/JNK Metabolic Pathway in Leukemic Cells Exposed to Etoposideionizing Radiation Combined Treatment
Author(s) -
Roberta Di Pietro,
Lucia Centurione,
Nadia Sabatini,
Domenico Bosco,
Silvia Sancilio,
Francesco Garaci,
R. Rana,
Amelia Cataldi
Publication year - 2004
Publication title -
international journal of immunopathology and pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 53
eISSN - 2058-7384
pISSN - 0394-6320
DOI - 10.1177/039463200401700210
Subject(s) - jurkat cells , apoptosis , caspase , etoposide , ionizing radiation , programmed cell death , dna damage , microbiology and biotechnology , chemistry , intracellular , cancer research , biology , biochemistry , immunology , dna , genetics , chemotherapy , t cell , irradiation , physics , immune system , nuclear physics
Ionizing radiation induces a series of multiple intracellular events which can lead to activation of caspases, cytoplasmic proteases involved in the occurrence of apoptosis. The response of leukemic cells to ionizing radiation is amplified when they have been pre-treated with the anticancer drug etoposide, therefore the aim of this work has been to establish the lowest etoposide concentration combined with the lowest ionizing radiation dose to obtain the best antineoplastic response. Two leukemic cell lines, HL-60 and Jurkat, employed in this study demonstrated different sensitivities to ionizing radiation and to etoposide treatment, with Jurkat T cells requiring a higher dose (1 microM) to display cell cycle perturbation and apoptotic DNA damage similar to those seen in HL-60. We hypothesize that this kind of response could be mediated by mitochondrial release of apoptogenic factors and by SAPK/JNK metabolic pathway activation, both leading to caspase-3 cleavage. All in all these results provide insight into the sensitivity or resistance of leukemic cells to antineoplastic agents and identify molecular targets for rational therapeutic intervention strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom